- In vitro susceptibilities of bacteroides fragilis group organisms: comparison of the strains isolated in 1990 with 1991
-
Lee KW, Jung YS, Kwon OH, Chang IH, Yoon KJ, Kim SJ
- KMID: 1699692
- Korean J Infect Dis.
- 1993 Feb;25(1):27-32.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Patient-Specific Tumor Microenvironment Models
-
Lee JW, Kim J, Shin Y, Chi BH, Kim JH, Chang IH, Choi SY
- KMID: 2527254
- Korean J Urol Oncol.
- 2022 Feb;20(1):69-69.
- doi: 10.22465/kjuo.2022.20.1.69
-
- CITED
-
- Close
- SHARE
-
- Close
- The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment
-
Choi DS, Kang SJ, Chang IH, Choi YW
- KMID: 2513365
- Korean J Urol Oncol.
- 2021 Feb;19(1):30-39.
- doi: 10.22465/kjuo.2021.19.1.30
Urothelial cancer is the seventh most common cancer among men worldwide. Bacille de Calmette-Guérin is a type of anticancer immunotherapy that has been used to treat targeted bladder cancer, but... -
- CITED
-
- Close
- SHARE
-
- Close
- Vascularization Methods for Tissue Engineers
-
Kim MJ, Chi BH, Cho MJ, Whang YM, Chang IH
- KMID: 2391193
- Korean J Urol Oncol.
- 2017 Aug;15(2):51-58.
- doi: 10.22465/kjuo.2017.15.2.51
Tissue engineering is limited by our inability to adequately vascularize tissues post implantation because all tissue-engineered substitutes (with the exception of cornea and cartilage) require a vascular network to provide... -
- CITED
-
- Close
- SHARE
-
- Close
- The Present and Future of Intravesical Therapy in Bladder Cancer
-
Seong SW, Shin Y, Chang IH, Kim JH
- KMID: 2530294
- Korean J Urol Oncol.
- 2022 May;20(2):82-91.
- doi: 10.22465/kjuo.2022.20.2.82
Intravesical therapy is the gold standard in the treatment of nonmuscle invasive bladder cancer (NMIBC). Despite the efficacy of intravesical therapies, the best treatment options are not determined yet. Development... -
- CITED
-
- Close
- SHARE
-
- Close
- Manipulating the Angiogenesis by Inflammation
-
Kim MJ, Jin S, Whang YM, Chang IH
- KMID: 2379753
- Korean J Urol Oncol.
- 2017 Apr;15(1):1-10.
- doi: 10.22465/kjuo.2017.15.1.1
There exists a need to develop strategies that promote neovascularization in virtually all tissue engineering and regenerative medicine efforts. While research typically focuses on understanding and exploiting the role of... -
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: Correction of Acknowledgement. Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway
-
Kim SJ, Seo HK, Seo HH, Lee SJ, Kwon JK, Lee TJ, Chi BH, Chang IH
- KMID: 1774475
- J Korean Med Sci.
- 2014 Apr;29(4):617-617.
- doi: 10.3346/jkms.2014.29.4.617
We found an error in our published article. -
- CITED
-
- Close
- SHARE
-
- Close
- Recombinant Bacille Calmette–Guérin for Immunotherapy in Nonmuscle Invasive Bladder Cancer
-
Jin S, Whang YM, Chang IH
- KMID: 2368943
- Korean J Urol Oncol.
- 2016 Dec;14(3):109-117.
- doi: 10.22465/kjuo.2016.14.3.109
Intravesical instillation of Mycobacterium bovis bacille Calmette–Guérin (BCG) has been used for treating nonmuscle invasive bladder cancer as the forefront of immunotherapy, but BCG is ineffective in approximately 30–40% of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Implications of Urinary Microbiome in Bladder Cancer
-
Shim JH, Gook JH, Chang IH, Sohn JM, Seong SW, Chi BH
- KMID: 2516479
- Korean J Urol Oncol.
- 2021 May;19(2):71-78.
- doi: 10.22465/kjuo.2021.19.2.71
Microbiomes are known to have a beneficial effect on human health by promoting the effective removal of improperly functioning immune cells and protecting the host from pathogen infection. On the... -
- CITED
-
- Close
- SHARE
-
- Close
- Laparoscopic Repair of Large Bladder Herniation Presenting as an Inguinal Hernia
-
Lee JY, Oh SY, Chang IH, Choe JW, Park SH, Ryu JH, Lee DM, Ryu YW, Lim SW
- KMID: 2316079
- Korean J Urol.
- 2013 Feb;54(2):139-142.
The bladder is involved in 1% to 3% of all hernia cases. We report a case of a large paraperitoneal bladder hernia (BH) in a 59-year-old man who had a... -
- CITED
-
- Close
- SHARE
-
- Close
- A novel strategy for treatment of bladder cancer: Antibody-drug conjugates
-
Kim JH, Chang IH
- KMID: 2530906
- Investig Clin Urol.
- 2022 Jul;63(4):373-384.
- doi: 10.4111/icu.20220061
In the past, there was no second-line chemotherapeutic agent suitable for use when urothelial carcinoma (UC) progressed to platinum-resistant UC. However, recently, several new treatment options, such as immune checkpoint... -
- CITED
-
- Close
- SHARE
-
- Close
- The Overdiagnosis of Kidney Cancer in Koreans and the Active Surveillance on Small Renal Mass
-
Chi BH, Chang IH
- KMID: 2439398
- Korean J Urol Oncol.
- 2018 Apr;16(1):15-24.
- doi: 10.22465/kjuo.2018.16.1.15
While overtreatment in medical services had been the topic of interest among the medical community for a long time, there are numerous academic papers concerning over-diagnosis nowadays. The use of... -
- CITED
-
- Close
- SHARE
-
- Close
- Nanomedicines for Therapy of Bladder Cancer
-
Song C, Jang SJ, Jeon WH, Maeng S, Tae JH, Chang IH
- KMID: 2536652
- Korean J Urol Oncol.
- 2022 Nov;20(4):235-247.
- doi: 10.22465/kjuo.2022.20.4.235
Bladder cancer is one of most common malignant urinary tract tumor types, and transurethral resection of nonmuscle invasive bladder cancer followed by intravesical instillation of immunochemotherapy is the standard treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Application of Bioprinting to Cancer Research
-
Cho MJ, Chi BH, Kim MJ, Whang YM, Chang IH
- KMID: 2438594
- Korean J Urol Oncol.
- 2018 Aug;16(2):52-57.
- doi: 10.22465/kjuo.2018.16.2.52
Three-dimensional (3D) printing is an additive manufacturing process by which precursor materials are deposited layer by layer to form complex 3D geometries from computer-aided designs, and bioprinting offers the ability... -
- CITED
-
- Close
- SHARE
-
- Close
- Animal models of bone metastatic prostate cancer
-
Tae JH, Chang IH
- KMID: 2542245
- Investig Clin Urol.
- 2023 May;64(3):219-228.
- doi: 10.4111/icu.20230026
Metastatic disease is a main cause of mortality in prostate cancer and remains to be incurable despite emerging new treatment agents. Development of novel treatment agents are confined within the... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting Recurrence and Progession of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors
-
Choi SY, Chang IH
- KMID: 2307827
- Korean J Urol Oncol.
- 2015 Apr;13(1):1-10.
- doi: 10.0000/kjuo.2015.13.1.1
About 80% of Bladder cancer is non muscle invasive bladder cancer (NMIBC). Despite of appropriate therapy, a lot of NMIBC recur as a superficial tumor or progress to muscle invasive... -
- CITED
-
- Close
- SHARE
-
- Close
- Delayed Presentation of Intravesical Bone Penetration after Pelvic Ring Fracture
-
Kim JH, Ha YC, Kim TH, Myung SC, Moon YT, Kim KD, Chang IH
- KMID: 1988738
- Korean J Urol.
- 2012 Dec;53(12):887-889.
- doi: 10.4111/kju.2012.53.12.887
Retrograde cystography and computed tomography (CT) are considered the gold standard for investigating bladder and pelvic bone injury. However, these methods can miss extraperitoneal bladder rupture caused by a penetrating... -
- CITED
-
- Close
- SHARE
-
- Close
- New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
-
Jeong J, Ha JB, Chang IH
- KMID: 2527247
- Korean J Urol Oncol.
- 2022 Feb;20(1):12-24.
- doi: 10.22465/kjuo.2022.20.1.12
For intermediate- and high-risk nonmuscle invasive bladder cancer (NMIBC), intravesical Bacillus Calmette-Guérin (BCG) therapy is the standard adjuvant treatment following transurethral resection of bladder tumor. Although intravesical BCG therapy improves... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma
-
Suh JY, Maeng SJ, Kim M, Kang SJ, Choi YW, Chang IH
- KMID: 2536651
- Korean J Urol Oncol.
- 2022 Nov;20(4):223-234.
- doi: 10.22465/kjuo.2022.20.4.223
Clear cell renal cell carcinoma (ccRCC) is a disease with a wide variety of clinical progressions such as the rate of disease progression or the degree of metastasis. About 30%... -
- CITED
-
- Close
- SHARE
-
- Close
- Animal Models for Bone Metastatic Prostate Cancer
-
Jeon WH, Song C, Jang SJ, Maeng S, Chang IH, Tae JH
- KMID: 2536653
- Korean J Urol Oncol.
- 2022 Nov;20(4):248-256.
- doi: 10.22465/kjuo.2022.20.4.248
Metastatic disease is a main cause of mortality in prostate cancer and remains to be uncurable despite emerging new treatment agents. Development of novel treatment agents are confined within the... -
- CITED
-
- Close
- SHARE
-
- Close
